about
Genome-wide association with select biomarker traits in the Framingham Heart StudyAssociation of plasma leptin levels with incident Alzheimer disease and MRI measures of brain agingAssociation of plasma total homocysteine levels with subclinical brain injury: cerebral volumes, white matter hyperintensity, and silent brain infarcts at volumetric magnetic resonance imaging in the Framingham Offspring StudyWarfarin and aspirin use and the predictors of major bleeding complications in atrial fibrillation (the Framingham Heart Study)Consent for genetic research in the Framingham Heart StudyDevelopment of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort studyThe Framingham Heart Study clock drawing performance: normative data from the offspring cohort.APOE genotype and MRI markers of cerebrovascular disease: systematic review and meta-analysis.Managing and analysing data from a large-scale study on Framingham Offspring relating brain structure to cognitive function.The lifetime risk of stroke: estimates from the Framingham Study.The Framingham Heart Study 100K SNP genome-wide association study resource: overview of 17 phenotype working group reportsGenetic correlates of brain aging on MRI and cognitive test measures: a genome-wide association and linkage analysis in the Framingham Study.Framingham Heart Study 100K project: genome-wide associations for cardiovascular disease outcomes.Carotid artery atherosclerosis, MRI indices of brain ischemia, aging, and cognitive impairment: the Framingham studyAssociation of MRI markers of vascular brain injury with incident stroke, mild cognitive impairment, dementia, and mortality: the Framingham Offspring StudyParental occurrence of stroke and risk of stroke in their children: the Framingham studyAssociation of alcohol consumption with brain volume in the Framingham study.Profiles by sex of brain MRI and cognitive function in the framingham offspring studyGenomewide linkage analysis for internal carotid artery intimal medial thickness: evidence for linkage to chromosome 12.Association of matrix metalloproteinases with MRI indices of brain ischemia and agingPlasma homocysteine as a risk factor for dementia and Alzheimer's disease.Interactive effects of apolipoprotein E type 4 genotype and cerebrovascular risk on neuropsychological performance and structural brain changes.Free testosterone levels are associated with mobility limitation and physical performance in community-dwelling men: the Framingham Offspring StudyGenome-wide association studies of MRI-defined brain infarcts: meta-analysis from the CHARGE Consortium.Cardiac index is associated with brain aging: the Framingham Heart StudyWhite matter hyperintensity and cognitive functioning in the racial and ethnic minority cohort of the Framingham Heart StudyA risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community: the Framingham Heart Study.Plasma natriuretic peptide levels and the risk of cardiovascular events and death.Parental atrial fibrillation as a risk factor for atrial fibrillation in offspring.Genome-wide analysis of genetic loci associated with Alzheimer disease.Lipoprotein phospholipase A2 and cerebral microbleeds in the Framingham Heart Study.Segment-specific association between plasma homocysteine level and carotid artery intima-media thickness in the Framingham Offspring Study.Genetics of the Framingham Heart Study populationValidation of an atrial fibrillation risk algorithm in whites and African Americans.Lifetime risk for development of atrial fibrillation: the Framingham Heart Study.Operationalizing diagnostic criteria for Alzheimer's disease and other age-related cognitive impairment-Part 2.Leukocyte telomere length and carotid artery intimal medial thickness: the Framingham Heart StudyObesity, diabetes and cognitive deficit: The Framingham Heart Study.Relation of obesity to cognitive function: importance of central obesity and synergistic influence of concomitant hypertension. The Framingham Heart Study.Genome-wide association studies of cerebral white matter lesion burden: the CHARGE consortium.
P50
Q21261433-A18A550F-6093-4697-A72F-596A1524344FQ24629027-0DF44508-B6BA-40C8-8673-4194DBB3F629Q24658404-83277C86-D4E0-4BB8-B056-413DB473999BQ28214210-38D88135-3F94-4F93-A393-BBE5EA6A3BC1Q28749646-059BB0EB-8E00-4625-8F05-0639DA81E7F2Q30491056-E4A88516-49C0-4567-9B2E-35F27B449048Q30585963-AB468168-A494-4989-A631-9761E30E4A41Q30655480-57319993-8FFA-480E-9803-BD8901D912D5Q33196714-C8D776A0-BF8F-4540-A4F2-F778F14D36E8Q33231050-DF9E2B8F-F2B1-49D5-A95E-2517039A35B8Q33300809-B21DBD15-703A-48FA-AF95-25FA3157FEE8Q33300810-AF7CA711-5637-49F6-99E3-1F1373B6CED3Q33300816-987D4B58-5C94-4B55-B0C2-9CE5C5D12829Q33415303-CDB7EE0F-518A-47A2-B2A6-04C2A85CF035Q33762168-762AA9CF-625F-4BA6-B9B4-B8437C5EA319Q33813228-D0B1C706-4327-4659-9865-0EC48BFF5D1EQ33817366-102A7B8B-4A6C-4AF7-AA81-3BF3228D5872Q33887346-A91CD2F3-E47A-4223-A438-15EB7F3503BCQ33909610-4EF55117-0901-472E-905F-C1830C530017Q33936858-A45B2E82-A1DE-43B5-AD6E-407A267617E4Q33957399-0CBBDDBB-BF04-438F-9208-6F49A6FDF2D4Q33976938-3092C801-231F-46C9-AFDA-937AE7E61364Q33984860-75C99E33-F4E1-414A-98B2-4DB891BA6631Q34071362-3ABB5681-80FE-4CD2-B404-84FE8FE78E62Q34090309-C9E145ED-91B5-4399-A9F3-D967EFA2BBCBQ34154008-3BF9D165-0443-4B9E-9722-A5C1252FB0E9Q34225539-058FCE2B-D4E5-4EC2-ACC2-93B747822A2EQ34298401-864854E5-0918-40DF-9D3E-C8637E848E46Q34327141-DD2083D0-CABA-4346-8870-1AF963185BF0Q34339530-DFC861A3-3044-46DE-899B-494E5A31C95BQ34409569-21AED94F-D4AD-4B9B-90FA-3F2217F683E4Q34444470-54987226-1142-45E7-9D6B-89CCDDF721CBQ34458072-92C05060-BC41-4A5F-9A2B-37554842355EQ34495006-89D11440-82AE-48D9-A8AB-2C0D858CA148Q34550202-0E5AF142-ADDB-4F26-9505-F1170F7D27EAQ34577636-917F58ED-F999-4000-8E44-A34923064528Q34588932-37E09E5F-F4F6-42CA-98A3-983FB36DA881Q34651098-634044D2-1F52-407C-9EFB-601AB09B64F1Q34653853-E620BFDC-E58A-4878-9551-CD36FE4F401FQ35065065-0D5F12E7-7FDB-439B-B694-30CDF56F63C7
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Philip A Wolf
@ast
Philip A Wolf
@en
Philip A Wolf
@es
Philip A Wolf
@nl
Philip A Wolf
@sl
type
label
Philip A Wolf
@ast
Philip A Wolf
@en
Philip A Wolf
@es
Philip A Wolf
@nl
Philip A Wolf
@sl
prefLabel
Philip A Wolf
@ast
Philip A Wolf
@en
Philip A Wolf
@es
Philip A Wolf
@nl
Philip A Wolf
@sl
P106
P21
P31
P496
0000-0002-3628-301X